Anti-MTMR14 antibody (ab228619)
- Datasheet
- References
- Protocols
Overview
-
Product name
Anti-MTMR14 antibody
See all MTMR14 primary antibodies -
Description
Rabbit polyclonal to MTMR14 -
Host species
Rabbit -
Tested applications
Suitable for: IHC-P, WBmore details -
Species reactivity
Reacts with: Human
Predicted to work with: Mouse, Rat, Cow
-
Immunogen
Recombinant fragment within Human MTMR14 (internal sequence). The exact sequence is proprietary.
Database link: Q8NCE2 -
Positive control
- WB: MOLT-4 whole cell lysate. IHC-P: Human colon carcinoma tissue.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 1.21% Tris, 0.75% Glycine, 20% Glycerol -
Concentration information loading... -
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Positive Controls
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab228619 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC-P | 1/100 - 1/1000. | |
| WB | 1/500 - 1/3000. Predicted molecular weight: 72 kDa. |
Target
-
Function
Lipid phosphatase which efficiently dephosphorylates phosphatidylinositol 3-phosphate (PtdIns3P) and PtdIns(3,5)P2; inactive toward PtdIns4P, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3. -
Tissue specificity
Expressed in various tissues, including heart, skeletal muscle, placenta, liver, lung, kidney and pancreas. -
Involvement in disease
Defects in MTMR14 may be a cause of centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150]; also known as autosomal dominant myotubular myopathy. Centronuclear myopathies are congenital muscle disorders characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers. -
Sequence similarities
Belongs to the protein-tyrosine phosphatase family. Non-receptor class myotubularin subfamily. -
Cellular localization
Cytoplasm. Found in reticular structures and plasma membrane ruffles. Concentrated near the nucleus. - Information by UniProt
-
Database links
- Entrez Gene: 514596 Cow
- Entrez Gene: 64419 Human
- Entrez Gene: 97287 Mouse
- Entrez Gene: 312634 Rat
- Omim: 611089 Human
- SwissProt: Q8NCE2 Human
- SwissProt: Q8VEL2 Mouse
- Unigene: 475382 Human
see all -
Alternative names
- C3orf29 antibody
- Egg derived tyrosine phosphatase homolog antibody
- FLJ11546 antibody
see all
Images
-
Western blot - Anti-MTMR14 antibody (ab228619)Anti-MTMR14 antibody (ab228619) at 1/2000 dilution + MOLT-4 (human lymphoblastic leukemia cell line) whole cell lysate at 30 µg
Predicted band size: 72 kDa7.5% SDS-PAGE gel.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTMR14 antibody (ab228619)Paraffin-embedded human colon carcinoma tissue stained for MTMR14 using ab228619 at 1/500 dilution in immunohistochemical analysis.
References
ab228619 has not yet been referenced specifically in any publications.
